Ahmad Taftaf
Overview
Explore the profile of Ahmad Taftaf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bilateral Facial Paralysis in an Atypical Clinical Onset of COVID-Associated Guillain-Barre Syndrome
Taftaf A, Vera Cruz C, Al-Qasmi H, Al-Qasmi M
Cureus
. 2024 Jul;
16(6):e63498.
PMID: 39081416
Coronavirus disease (COVID-19) has been associated with a diverse range of extrapulmonary manifestations since its global outbreak in 2019. One of its rare complications is Guillain-Barre Syndrome (GBS), a post-infectious...
2.
Alsayid M, Taftaf A, Harmouch K, Alabkaa A, Pappas S, Singh A
ACG Case Rep J
. 2023 Feb;
10(1):e00964.
PMID: 36743331
Sarcoidosis is an inflammatory disease that affects multiple organs. The lungs are the most commonly involved organs. Although a large proportion of patients with sarcoidosis have liver involvement, bile duct...
3.
Karivedu V, Eldessouki I, Correa Z, Taftaf A, Zhu Z, Makramalla A, et al.
Case Rep Oncol Med
. 2019 Nov;
2019:3868790.
PMID: 31772797
[This corrects the article DOI: 10.1155/2019/3560640.].
4.
Karivedu V, Eldessouki I, Taftaf A, Zhu Z, Makramalla A, Karim N
Case Rep Oncol Med
. 2019 Jun;
2019:3560640.
PMID: 31179139
Background: Metastatic uveal melanoma (MUM) is associated with a poor prognosis, with a median overall survival (OS) of 4-15 months. Despite new insights into the genetic and molecular background of...
5.
Karim N, Eldessouki I, Taftaf A, Ayham D, Gaber O, Makramalla A, et al.
Case Rep Oncol Med
. 2018 Jun;
2018:4256365.
PMID: 29850322
Metastatic prognosis in uveal melanoma is assessed by gene expression profiling (GEP) testing of the tumor cells, usually obtained by fine needle aspiration (FNA). GEP has demonstrated high accuracy in...